These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 28911065)
1. Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment. Holch P; Warrington L; Bamforth LCA; Keding A; Ziegler LE; Absolom K; Hector C; Harley C; Johnson O; Hall G; Morris C; Velikova G Ann Oncol; 2017 Sep; 28(9):2305-2311. PubMed ID: 28911065 [TBL] [Abstract][Full Text] [Related]
2. Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice (eRAPID): a randomised controlled trial in systemic cancer treatment. Absolom K; Holch P; Warrington L; Samy F; Hulme C; Hewison J; Morris C; Bamforth L; Conner M; Brown J; Velikova G; BMC Cancer; 2017 May; 17(1):318. PubMed ID: 28482877 [TBL] [Abstract][Full Text] [Related]
3. eRAPID electronic patient self-Reporting of Adverse-events: Patient Information and aDvice: a pilot study protocol in pelvic radiotherapy. Holch P; Pini S; Henry AM; Davidson S; Routledge J; Brown J; Absolom K; Gilbert A; Franks K; Hulme C; Morris C; Velikova G; Pilot Feasibility Stud; 2018; 4():110. PubMed ID: 29992040 [TBL] [Abstract][Full Text] [Related]
4. Engaging Patients and Clinicians in Online Reporting of Adverse Effects During Chemotherapy for Cancer: The eRAPID System (Electronic Patient Self-Reporting of Adverse Events: Patient Information and aDvice). Absolom K; Gibson A; Velikova G Med Care; 2019 May; 57 Suppl 5 Suppl 1():S59-S65. PubMed ID: 30985598 [TBL] [Abstract][Full Text] [Related]
5. Online tool for monitoring adverse events in patients with cancer during treatment (eRAPID): field testing in a clinical setting. Warrington L; Absolom K; Holch P; Gibson A; Clayton B; Velikova G BMJ Open; 2019 Feb; 9(1):e025185. PubMed ID: 30782751 [TBL] [Abstract][Full Text] [Related]
6. Asking the right questions to get the right answers: using cognitive interviews to review the acceptability, comprehension and clinical meaningfulness of patient self-report adverse event items in oncology patients. Holch P; Warrington L; Potrata B; Ziegler L; Hector C; Keding A; Harley C; Absolom K; Morris C; Bamforth L; Velikova G Acta Oncol; 2016; 55(9-10):1220-1226. PubMed ID: 27551774 [TBL] [Abstract][Full Text] [Related]
7. A real-time electronic symptom monitoring system for patients after discharge following surgery: a pilot study in cancer-related surgery. Richards HS; Blazeby JM; Portal A; Harding R; Reed T; Lander T; Chalmers KA; Carter R; Singhal R; Absolom K; Velikova G; Avery KNL BMC Cancer; 2020 Jun; 20(1):543. PubMed ID: 32522163 [TBL] [Abstract][Full Text] [Related]
8. Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy. Absolom K; Warrington L; Hudson E; Hewison J; Morris C; Holch P; Carter R; Gibson A; Holmes M; Clayton B; Rogers Z; McParland L; Conner M; Glidewell L; Woroncow B; Dawkins B; Dickinson S; Hulme C; Brown J; Velikova G J Clin Oncol; 2021 Mar; 39(7):734-747. PubMed ID: 33417506 [TBL] [Abstract][Full Text] [Related]
9. Developing a real-time electronic symptom monitoring system for patients after discharge following cancer-related surgery. Avery KNL; Richards HS; Portal A; Reed T; Harding R; Carter R; Bamforth L; Absolom K; O'Connell Francischetto E; Velikova G; Blazeby JM BMC Cancer; 2019 May; 19(1):463. PubMed ID: 31101017 [TBL] [Abstract][Full Text] [Related]
10. Feasibility, usability and acceptance of weekly electronic patient-reported outcomes among patients receiving pelvic CT- or online MR-guided radiotherapy - A prospective pilot study. Møller PK; Pappot H; Bernchou U; Schytte T; Mortensen ZV; Brúnni MFÁ; Dieperink KB Tech Innov Patient Support Radiat Oncol; 2022 Mar; 21():8-15. PubMed ID: 34977367 [TBL] [Abstract][Full Text] [Related]
11. Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and research. McFatrich M; Brondon J; Lucas NR; Hinds PS; Maurer SH; Mack JW; Freyer DR; Jacobs SS; Baker JN; Mowbray C; Wang M; Castellino SM; Barz Leahy A; Reeve BB Cancer; 2020 Jan; 126(1):140-147. PubMed ID: 31553494 [TBL] [Abstract][Full Text] [Related]
12. Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Chung AE; Shoenbill K; Mitchell SA; Dueck AC; Schrag D; Bruner DW; Minasian LM; St Germain D; O'Mara AM; Baumgartner P; Rogak LJ; Abernethy AP; Griffin AC; Basch EM J Am Med Inform Assoc; 2019 Apr; 26(4):276-285. PubMed ID: 30840079 [TBL] [Abstract][Full Text] [Related]
13. Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative. Reeve BB; McFatrich M; Pinheiro LC; Weaver MS; Sung L; Withycombe JS; Baker JN; Mack JW; Waldron MK; Gibson D; Tomlinson D; Freyer DR; Mowbray C; Jacobs S; Palma D; Martens CE; Gold SH; Jackson KD; Hinds PS Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27650708 [TBL] [Abstract][Full Text] [Related]
14. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Basch E; Reeve BB; Mitchell SA; Clauser SB; Minasian LM; Dueck AC; Mendoza TR; Hay J; Atkinson TM; Abernethy AP; Bruner DW; Cleeland CS; Sloan JA; Chilukuri R; Baumgartner P; Denicoff A; St Germain D; O'Mara AM; Chen A; Kelaghan J; Bennett AV; Sit L; Rogak L; Barz A; Paul DB; Schrag D J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25265940 [TBL] [Abstract][Full Text] [Related]
15. Online Symptom Monitoring During Pelvic Radiation Therapy: Randomized Pilot Trial of the eRAPID Intervention. Holch P; Absolom KL; Henry AM; Walker K; Gibson A; Hudson E; Rogers Z; Holmes M; Peacock R; Pini S; Gilbert A; Davidson S; Routledge J; Murphy A; Franks K; Hulme C; Hewison J; Morris C; McParland L; Brown J; Velikova G Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):664-676. PubMed ID: 36241128 [TBL] [Abstract][Full Text] [Related]
16. Online monitoring of patient self-reported adverse events in early phase clinical trials: Views from patients, clinicians, and trial staff. Kennedy F; Shearsmith L; Ayres M; Lindner OC; Marston L; Pass A; Danson S; Velikova G Clin Trials; 2021 Apr; 18(2):168-179. PubMed ID: 33231103 [TBL] [Abstract][Full Text] [Related]
17. Patient-reported outcomes and the evolution of adverse event reporting in oncology. Trotti A; Colevas AD; Setser A; Basch E J Clin Oncol; 2007 Nov; 25(32):5121-7. PubMed ID: 17991931 [TBL] [Abstract][Full Text] [Related]
18. Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials. Basch E; Dueck AC; Rogak LJ; Minasian LM; Kelly WK; O'Mara AM; Denicoff AM; Seisler D; Atherton PJ; Paskett E; Carey L; Dickler M; Heist RS; Himelstein A; Rugo HS; Sikov WM; Socinski MA; Venook AP; Weckstein DJ; Lake DE; Biggs DD; Freedman RA; Kuzma C; Kirshner JJ; Schrag D JAMA Oncol; 2017 Aug; 3(8):1043-1050. PubMed ID: 28208174 [TBL] [Abstract][Full Text] [Related]
19. Electronic Patient Reporting of Adverse Events and Quality of Life: A Prospective Feasibility Study in General Oncology. Kennedy F; Absolom K; Clayton B; Rogers Z; Gordon K; O'Connell Francischetto E; Blazeby JM; Brown J; Velikova G JCO Oncol Pract; 2021 Mar; 17(3):e386-e396. PubMed ID: 32853122 [TBL] [Abstract][Full Text] [Related]